Chinese Biotech Firm LianBio Prices US$325 Million Nasdaq IPO

Biotech company LianBio (Nasdaq: LIAN) started trading on the Nasdaq Global Market today. The Shanghai-based firm aims to raise approximately US$325 million in its debut on the US big board.

The offering consisted of 20,312,500 American depositary shares at US$16.00 per ADS, which represents 1 ordinary company share. The ADSs will be trading on the Nasdaq exchange under the symbol “LIAN”.

Goldman Sachs & Co., Jefferies, and BofA Securities, Inc. are acting as the joint bookrunners for the said offering. The underwriters were given a 30-day over-allotment option to purchase up to an additional 3,046,875 ADSs at the same IPO price.

The company also has its offices in Princeton, New Jersey. According to its website, the firm aims “to bring transformative medicines to historically underserved patients in China and other Asian markets.”


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

What Happens If Silver Finally Breaks $50? | Gary Thompson – Silver47

Recommended

Emerita Resources Expands El Cura Drill Program By 10,000 Metres As Deposit Remains Open For Expansion

ESGold Signs MOU For Tailings Project In Colombia With Grades Up To 42 g/t Gold, 280 g/t Silver

Related News

Singapore-Based SPAC RF Acquisition Prices US$100 Million IPO

Special purpose acquisition company RF Acquisition Corp. (Nasdaq: RFACU) started trading its securities on the...

Thursday, March 24, 2022, 02:25:00 PM

Edtech Firm Instructure Eyes US$250 Million IPO

Education technology company Instructure Holdings began trading on the New York Stock Exchange today under...

Thursday, July 22, 2021, 01:25:00 PM

Nvidia Props Up Customer CoreWeave’s IPO

Nvidia will reportedly anchor the much-anticipated initial public offering of CoreWeave at $40 per share...

Sunday, March 30, 2025, 09:32:00 AM

SPAC Lakeshore Acquisition II Prices US$60 Million IPO

Special purpose acquisition company Lakeshore Acquisition II Corp. (Nasdaq: LBBBU) started trading publicly on the...

Wednesday, March 9, 2022, 12:06:00 PM

Robinhood Creating Platform to Allow Amateur Investors to Buy IPOs, Including its Own

While still brushing off daytrader anguish and congressional scrutiny after its decision to pause trading...

Saturday, March 27, 2021, 11:21:00 AM